Skip to main content
TOPRA
Toggle search
Keyword search
Toggle navigation
Keyword search
BECOME A MEMBER
CONTACT US
Sign in
About
Toggle
Our mission, vision and values
Our history
Governance
Who's who
Contact us
Find us
Partnerships and Affiliations
What is Regulatory Affairs?
Membership & Communities
Toggle
Join TOPRA
TOPRA Membership
Communities
Volunteering
Events
Toggle
Annual Lecture
Awards
Regulatory Careers Live
Symposium
TOPRA Summit
Professional Development
Toggle
Career progression
All courses & events
Training
Conferences & networking
Qualifications
Apprenticeship
Professional registration
CPD and lifelong learning
Degree accreditation
Publications & Resources
Toggle
News & insights
Regulatory Rapporteur
Members-only newsletters
TOPRA Engage+ App
TOPRA Connect newsletter
Medical device resources
Reg Intelligence Knowledge Hub
Sustainability
Wall Planner
Glossary of RA terms
Commercial Services
Toggle
Advertising opportunities
Exhibition opportunities
Sponsorship opportunities
Services directory
About TOPRA
Professional development
My TOPRA
TOPRA shop
Membership & communities
TOPRA services
Loading
Start date
Title
Description
City
Country
Hidden
28/10/2026
European MedTech Market: One Approval Isn’t Enough
DA approval often creates a false sense of readiness for MedTech companies entering Europe, where underestimating regulatory and clinical differences leads to Notified Body delays, evidence gaps, and unpredictable timelines under MDR and IVDR. Building on QbD Group's Landing in Europe whitepaper, this webinar explains why EU entry demands a different approach, covering clinical evidence expectations, Notified Body interactions, and the full lifecycle from gap assessment to CE marking and post-market compliance. Register to assess your true EU readiness, avoid costly delays, and learn what it really takes to succeed in Europe.
Online
QBDOCT26
03/11/2026
Overview of EU and UK Regulatory Affairs
Gain a comprehensive introduction to the pharmaceutical development pathway and the EU and UK regulatory systems that support it, with insight into the essential contribution regulatory affairs makes across the lifecycle of a medicine. This course is also Module 0 of the MSc programme.
Vienna
Austria
IC22026F
03/11/2026
Overview of EU and UK Regulatory Affairs
Gain a comprehensive introduction to the pharmaceutical development pathway and the EU and UK regulatory systems that support it, with insight into the essential contribution regulatory affairs makes across the lifecycle of a medicine.
Online
IC22026O
03/11/2026
The Role of AI in Healthcare and Regulatory Webinar
Artificial Intelligence (AI) is transforming healthcare through faster diagnoses, personalised treatments, and greater efficiency. As AI adoption accelerates, regulators worldwide are working to ensure its safe, transparent, and accountable use. Join this webinar to explore the regulatory thinking shaping AI governance, the challenge of balancing innovation with patient protection, and the ethical and compliance considerations of using AI in healthcare.
Online
INDIA26
10/11/2026
Optimising Regulatory Strategies for Orphan Drugs
Discover the strategies and insights needed to navigate orphan drug regulations effectively. This course provides essential guidance on regulatory processes that accelerate development and access, along with first-hand advice on how to maximise opportunities for rare disease medicines.
Online
CODON
12/11/2026
Introduction To TOPRA - Make the Most of Your Membership
Welcome to TOPRA! Make sure you join our webinar on 25 February 2026 to find out how you can make the most of your membership.
Online
MEMNOV26
12/11/2026
Project Management for Regulatory Affairs Professionals
A two-day course that strengthens your ability to manage regulatory projects, lead teams and deliver high-quality regulatory documents.
Online
PM26O
18/11/2026
Regulatory Strategy for a New Active Substance Nonclinical
Module 2 of the MSc and Masterclass: This Masterclass will give delegates an understanding of the practical and legislative requirements for the nonclinical phase of global drug development. It will explore the regulatory issues that are likely to arise and provide advice and discussion around solutions to such situations.
London
United Kingdom
MSCM26F
18/11/2026
Regulatory Strategy for a New Active Substance Nonclinical
This Masterclass will give delegates an understanding of the practical and legislative requirements for the nonclinical phase of global drug development. It will explore the regulatory issues that are likely to arise and provide advice and discussion around solutions to such situations.
Online
MSCM26O
18/11/2026
From Strategy To First-In-Human Webinar
Gain a practical roadmap for progressing from development strategy to First-in-Human (FIH) readiness. Covering non-clinical development, CMC strategy, clinical operations and Clinical Trial Application requirements, this webinar will help you build a credible and efficient path to the clinic.
Online
QBDNOV26
01/12/2026
Regulatory Strategy From Development To the Marketplace
Build regulatory strategies that protect brands and sustain market success. This Masterclass focuses on the real-world regulatory decisions that underpin effective product commercialisation and lifecycle management, enabling you to deliver confident, commercially aligned regulatory advice from development through to the marketplace. This course is also Module 6 of the MSc programme.
London
United Kingdom
MSCM626F
01/12/2026
Regulatory Strategy From Development To the Marketplace
Build regulatory strategies that protect brands and sustain market success. This Masterclass focuses on the real-world regulatory decisions that underpin effective product commercialisation and lifecycle management, enabling you to deliver confident, commercially aligned regulatory advice from development through to the marketplace.
Online
MSCM626O
08/12/2026
Successfully Navigating European Regulatory Procedures
This course is designed for individuals involved in developing European regulatory strategies for projects or wishing to gain the knowledge and skills to contribute to regulatory strategies.
London
United Kingdom
ERP26F2F
15/12/2026
Prescription To Non-Prescription Medicines Switch in EU
Navigating the Rx to OTC switch process in Europe takes more than regulatory knowledge. It requires strategy, market awareness and the ability to turn theory into action. This course equips you with all three, combining a thorough grounding in EU frameworks with practical case studies so you can apply what you learn from day one.
Online
CREDPNP26O
12/01/2027
Strategic Planning in Regulatory Affairs
This Masterclass will help you understand the practical and strategic aspects of global regulatory affairs, and enable you to develop your knowledge and skills to provide advice to your company to help develop a regulatory strategy. This course is also Module 1 of the MSc programme.
London
United Kingdom
MSCM12027F
12/01/2027
Strategic Planning in Regulatory Affairs
This Masterclass will help you understand the practical and strategic aspects of global regulatory affairs, and enable you to develop your knowledge and skills to provide advice to your company to help develop a regulatory strategy.
Online
MSCM12027O
26/01/2027
Post-Market Surveillance and Vigilance for Medical Devices
Strengthen your understanding of vigilance and post-market surveillance (PMS) and learn how to apply these essential processes throughout the medical device lifecycle. This Masterclass provides a clear, practical introduction to PMS systems and vigilance procedures, with a strong focus on meeting European regulatory expectations. This course is also Module 16 of the MSc Regulatory Affairs.
London
United Kingdom
MSCMD1627F
26/01/2027
Post-Market Surveillance and Vigilance for Medical Devices
Strengthen your understanding of vigilance and post-market surveillance (PMS) and learn how to apply these essential processes throughout the medical device lifecycle. This Masterclass provides a clear, practical introduction to PMS systems and vigilance procedures, with a strong focus on meeting European regulatory expectations.
Online
MSCMD1627O
Previous
Next
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##